US cancer drugs shortage crisis drives temporary drug importation, quick approval and draft guidance

The US Food and Drug Administration has taken steps to address the shortage of critically needed cancer drugs by allowing for the temporary importation into the US of one product that the agency has not yet approved and by speeding up its review and approval of another product1.